Ultragenyx Reports Third Quarter 2020 Financial Results and Corporate Update
Go back to Ultragenyx Reports Third Quarter 2020 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.98 +0.10 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.88 | 52 Week High | $117.12 | |||
| Open | $14.85 | 52 Week Low | $46.52 | |||
| Day High | $15.19 | P/E | N/A | |||
| Day Low | $14.75 | EPS | $-1.97 | |||
| Volume | 274,308 | |||||
